Dados B3 › Stocks › Utilities › SAPR11
Utilities
SAPR11 — CIA. DE SANEAMENTO DO PARANÁ - SANEPAR
Updated 2026-11-13 00:44 (Brasília time) · Source: B3 (COTAHIST) and CVM (DFP and ITR) · primary sources: DFP 2025 (CVM), B3 quotes file of 2026-11-12 · how we calculate
close of 2026-11-12 (B3)
earnings to 2T26, price of 2026-11-12
fiscal year 2025 (DFP, CVM)
equity at 2T26, price of 2026-11-12
SAPR11 paid R$ 1.96 per share in 2025 (dividends + interest on equity, gross; record date within the year); over the 12 months to 2026-11-13, R$ 0.55, dividend yield 1.7% on the 2026-11-12 close.
How to cite: Dados B3 — SAPR11: dividends, ratios and CVM filings, data through 2026-11-12. https://dadosb3.com/acoes/SAPR11?lang=en
CNPJ 76.484.013/0001-45 · listed classes: SAPR11, SAPR3, SAPR4 · CVM code 18627
EXPLORAÇÃO DE SERVIÇOS PÚBLICOS E DE SISTEMAS PRIVADOS DE ABASTECIMENTO DE ÁGUA, DE COLETA, REMOÇÃO E DESTINAÇÃO FINAL DE EFLUENTES E RESÍDUOS SÓLIDOS DOMÉSTICOS E INDUSTRIAIS E SEUS SUBPRODUTOS.As filed by the company in its registration form (FCA), reference 2026-01-01 · CVM sector: Saneamento, Serv. Água e Gás
Verdict
Net margin 28.9%; ROIC 14.2%; debt 0.6x EBITDA; P/E 6.7 at the price of 2026-02-26, when the statements came out; at the 2026-11-12 close, 4.7; sector 13.8; 2025 data, no relevant restatement.
Confidence flag: Clean data
Data for fiscal year 2025, received by the CVM on 2026-02-26; 5 of the 5 core figures published; last restatement recorded in 2021.
Does the company make money?
- Net margin of 28.9% in 2025; sector median 9.7% (45 companies); the company itself ranged from 9.2% to 28.9% between 2010 and 2025; 91% of the 330 companies in the base are below; margin above 15%. how we compute it
- Return on invested capital (ROIC) of 14.2% in 2025; sector median 14.0% (33 companies); the company itself ranged from 9.5% to 14.2% between 2011 and 2025; 51% of the 167 companies in the base are below; return below the average Selic rate of 2025 (14.4% a year, before tax). how we compute it
Is it sound or indebted?
- Net debt to EBITDA of 0.6 in 2025; sector median 2.8 (43 companies); the company itself ranged from 0.6 to 2.4 between 2010 and 2025; 71% of the 300 companies in the base are above; debt up to 2 times EBITDA. how we compute it
Is the share expensive or cheap relative to the sector and its own history?
- Price to earnings (P/E) of 6.7 in 2025 (price of 2026-02-26, the day the statements became public); at the latest close (2026-11-12) with the same earnings, 4.7; sector median 13.8 (10 companies; each at the price of the day its statements became public); 79% of the 114 companies in the base are above; note: market value computed from the unit basket. how we compute it
- Price to book (P/B) of 1.1 in 2025 (price of 2026-02-26, the day the statements became public); at the latest close (2026-11-12) with the same book value, 0.8; sector median 1.9 (10 companies; each at the price of the day its statements became public); 57% of the 114 companies in the base are above; note: market value computed from the unit basket; total equity used instead of the controlling shareholders' equity. how we compute it
Descriptive: number, numeric band and comparison with the sector, the company's own history and the whole universe. Not investment advice. JSON · how the verdict works
Quick answers: How much has it paid in dividends? · Has profit grown? · Has debt gone up?
Embed these charts (net income and ROE: ready-made cards for your blog or forum)
Quote
Price only: · 1m -21.4% · 12m -9.7% · YTD -19.2% · 52-week R$ 29.75–47.90
Return by window
| 1 month | 3 months | 1 year | 2 years | 5 years | 10 years | |
|---|---|---|---|---|---|---|
| Price only | -21.4% | +3.2% | -9.7% | +22.3% | +68.4% | — |
| With dividends reinvested | -21.4% | +3.2% | -8.4% | +32.5% | +124.6% | — |
| Difference: the dividends | +0.0 pp | +0.0 pp | +1.2 pp | +10.2 pp | +56.2 pp | — |
| Real, net of inflation (IPCA to 10/2026) | -21.4% | +2.5% | -12.4% | +21.2% | +76.1% | — |
| R$ 1,000 would be worth | R$ 786 | R$ 1,032 | R$ 916 | R$ 1,325 | R$ 2,246 | — |
Closing prices from the base up to 2026-11-12. The starting price is adjusted by the corporate actions checked against the price (the small mark says how many); a jump they do not explain leaves the window blank. Reinvestment buys more shares at the close of the ex-date, with no tax or cost; only the main ticker class. The real line divides the reinvested return by the IPCA accumulated in the window (Banco Central series 433, monthly, edge months pro rata by days); the latest month is only published around the 10th of the following month.
Buy-and-hold vs 21×100 moving-average crossover
| 2021-11-12 → 2026-11-12 | Price only | With dividends reinvested | Difference: the dividends (points) | …net of the JCP tax (15%) | Maximum drawdown (price) |
|---|---|---|---|---|---|
| Buy and hold | +68.41% | +124.60% | +56.19% | +115.34% | -37.89% |
| 21×100 crossover | +19.60% | +42.40% | +22.80% | +38.83% | -34.48% |
Closing price adjusted for corporate actions, with dividends, JCP and distributions reinvested on the ex-date, no tax; no costs; a session's crossover signal applies to the next one. Not a recommendation. Same numbers, with the premises and volatility, open, no key: /empresas/SAPR4/desempenho.
How much did R$ 1,000 in SAPR4 become in 1, 3, 5 and 10 years?
Corporate actions
| last day with rights | event | multiplier | net effect of the day | what the price said |
|---|---|---|---|---|
| 2020-03-27 | stock split (ON and PN and UNT) | 3.00× shares | — | confirmed against the price |
| 2002-03-22 | bonus issue | 1.25× shares | — | no trading on the ex-date |
Why the price chart jumps: prices are not split-adjusted. Events come from the exchange file (declared) and are checked against the price move; only those marked found by us were detected from the share count and the price. Several events on one day are one operation: the net effect column is what the price must have done. Every field, spin-offs included, is at /empresas/{ticker}/eventos.
Valuation
Today
close of 2026-11-12 × sharesprice × shares outstanding
+ net debt 2025market value + net debt
profit per sharenet income for the year ÷ shares
book value per shareshareholders' equity ÷ shares
to 2T26today's market value ÷ net income of the last 12 months (built by identity from the quarterly filings)
latest quarterly balancetoday's market value ÷ equity to controlling shareholders at quarter end
to 2T26net income of the last 12 months ÷ average equity over the same 12 months
to 2T26net income ÷ net revenue, both over the last 12 months
FCO R$ 7.1 bnmarket value ÷ operating cash flow
FCF R$ 4.4 bnmarket value ÷ (operating cash flow + capex)
Snapshot: today's close over the latest public share count. Cards marked 12m use the last four quarterly filings; the others use the 2025 annual filing. The multiples below are point-in-time: priced on the day the filing became public. share count caveat
At the filing date (point-in-time)
price of 2026-02-26 · sector 13.8 · 10 cos. · 1st of 11price ÷ earnings per share for the year
price of 2026-02-26 · sector 7.4 · 10 cos. · 2th of 11enterprise value on the filing date ÷ EBITDA for the year (other sites use trailing 12 months and today's price)
price of 2026-02-26 · sector 2.2% · 10 cos. · 1st of 11(operating cash flow + capex) ÷ market value
By theme, fiscal year 2025
Valuation
| P/Receita todaymarket value ÷ net revenue for the year | 1.36× |
| EV/Receita todayenterprise value ÷ net revenue | 1.61× |
| P/EBITDA todaymarket value ÷ EBITDA | 3.31× |
| P/EBIT todaymarket value ÷ EBIT | 4.20× |
| EV/EBIT todayenterprise value ÷ EBIT | 4.96× |
| Earning yield todaynet income ÷ market value (the inverse of P/E) | 21.2% |
Debt and liquidity
| Dívida líquida/PLnet debt ÷ shareholders' equity | 0.14× |
| Dívida bruta/PLshort- and long-term borrowings ÷ equity | 0.60× |
| Dívida líquida/EBITDAnet debt ÷ EBITDA for the year | 0.60× |
| PL/Ativosequity ÷ total assets | 0.47× |
| Passivos/Ativos(total assets − equity) ÷ total assets | 0.53× |
| Liquidez correntecurrent assets ÷ current liabilities | 1.20× |
Efficiency
| Margem brutagross profit ÷ net revenue | 56.3% |
| Margem EBITDAEBITDA ÷ net revenue | 41.1% |
| Margem EBITEBIT ÷ net revenue | 32.4% |
| Margem líquidanet income ÷ net revenue | 28.9% |
Profitability
| ROEnet income to controlling ÷ average equity | 17.9% |
| ROICEBIT × (1 − effective tax rate) ÷ average invested capital (gross debt + total equity − cash − investments), goodwill included | 14.2% |
| ROAnet income ÷ total assets | 8.9% |
| Giro do ativonet revenue ÷ total assets | 0.27× |
Growth
| Receita, 1 anorevenue this year ÷ previous year − 1 | 5.2% |
| Receita, CAGR 5 anoscompound annual growth of revenue over 5 years | 8.5% |
| Lucro, CAGR 5 anoscompound annual growth of net income over 5 years (positive at both ends only) | 15.9% |
| EBITDA, CAGR 5 anoscompound annual growth of EBITDA over 5 years (positive at both ends only) | 8.9% |
Standardized accounts and published indicators of the fiscal year; items marked today divide today's market value or enterprise value by an account of that year.
Exact definition: ROE and debt on this page (base date and CVM accounts)
ROE 2025: 17.95% = net income attributable to controlling shareholders in 2025 (R$ 2.08 bn, income statement 3.11;igual_ao_lucro_total_sem_minoritarios) ÷ average equity attributable to controlling shareholders (R$ 11.59 bn = average of R$ 10.83 bn on 2024-12-31 and R$ 12.35 bn on 2025-12-31; balance sheet, liabilities 2.03). Base date 2025-12-31 (fiscal year 2025). Source: DFP 2025 filed with the CVM on 2026-02-26.
This is the accounting ROE, reproducible from the statements filed with the CVM. The ROE a company reports in its own earnings release may use recurring or managerial net income and a different equity base; that figure is not in the DFP and is not reproduced here. Full formula: /metodologia/roe.
Net debt on 2025-12-31: R$ 1.78 bn = short-term borrowings (R$ 997.33 mn, balance sheet, liabilities 2.01.04) + long-term borrowings (R$ 6.40 bn, balance sheet, liabilities 2.02.01) − cash and equivalents (R$ 5.61 bn, balance sheet, assets 1.01.01) − financial investments (R$ 0, balance sheet, assets 1.01.02). Net debt/EBITDA 2025: 0.60× = R$ 1.78 bn ÷ EBITDA for 2025; EBITDA 2025: R$ 2.96 bn = EBIT R$ 2.34 bn (income statement 3.05) + depreciation and amortization R$ 626.25 mn (cash flow statement 6.01.01.02). In reais, consolidated balance sheet. Source: DFP 2025 filed with the CVM on 2026-02-26.
Net debt on 2026-06-30 (2T26, latest quarterly filing): R$ 2.59 bn, same accounts, from the ITR, filed on 2026-08-13. Net debt/12-month EBITDA to 2026-06-30: 0.96× = R$ 2.59 bn ÷ 12-month EBITDA R$ 2.70 bn. 12-month EBIT R$ 2.03 bn = EBIT 2025 R$ 2.34 bn (income statement 3.05) − 6M25 R$ 1.35 bn + 6M26 R$ 1.04 bn (sum of the stand-alone quarters in the ITR). 12-month depreciation and amortization R$ 668.25 mn = 2025 R$ 626.25 mn (cash flow statement 6.01.01.02) − year-to-date 6M25 R$ 305.25 mn + year-to-date 6M26 R$ 347.25 mn (year-to-date cash flow statement 6.01.01.02). The prior-year pieces match the comparative column of the current ITR.
The net debt a company reports in its own earnings release may be in another currency, at another base date and with other adjustments; that figure is not in the CVM filings we use and is not reproduced here. Formula: /metodologia/divida_liquida_ebitda.
Indicators, year by year
Four indicators as charts and the full table below. A hollow point carries a caveat; a gap is a year without the figure — we never draw a line across a hole. In the table, the arrow opens the path from the figure down to the line in the regulator's file; a cell with ! carries a caveat; a dashed dash is a suppressed figure — hover to see why. Nothing is hidden.
Fact checklist 9 of 9
- ✓More than 5 years of trading in our data 9.0 years
- ✓Profit in each of the last 5 fiscal years no losses
- ✓Never a loss in the base's history no losses
- ✓Latest-year ROE above 10% 17.9%
- ✓Revenue grew over 5 years (positive CAGR) 8.5%
- ✓Profit grew over 5 years (positive CAGR) 15.9%
- ✓Gross debt below equity debt = 60% of equity
- ✓Average yield of the last 5 years at least 5% 5.9% (median 5.6%)
- ✓Average daily traded value above R$ 10 million R$ 72.0 m/day
Nine objective checks with the threshold written in each line and the figure behind it. Descriptive, not a recommendation; the thresholds are ours and are declared.
Full table
| indicator | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | sector |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE ⟶audit | 6.2%! | 12.7% | 14.2% | 13.4% | 11.4% | 11.0% | 13.9% | 13.8% | 16.4% | 18.2% | 15.2% | 15.9% | 13.9% | 16.2% | 15.0% | 17.9% | 14.6% |
| ROIC ⟶audit | 7.4%! | 12.3% | 13.7% | 11.8% | 9.6% | 9.5% | 11.4% | 12.0% | 13.6% | 14.2% | 12.3% | 13.3% | 11.3% | 13.0% | 11.8% | 14.2% | 14.0% |
| ROA ⟶audit | 2.6%! | 5.2% | 5.7% | 6.2% | 5.9% | 5.6% | 7.1% | 7.0% | 8.5% | 9.5% | 7.9% | 8.5% | 7.4% | 8.5% | 7.9% | 8.9% | 4.5% |
| Gross margin ⟶audit | 54.9% | 58.3% | 61.4% | 60.3% | 57.4% | 54.7% | 58.4% | 59.8% | 59.6% | 60.6% | 60.0% | 60.6% | 58.0% | 60.0% | 57.8% | 56.3% | 27.8% |
| EBIT margin ⟶audit | 21.1% | 28.4% | 26.9% | 27.1% | 25.2% | 23.6% | 27.4% | 29.4% | 32.9% | 34.6% | 32.7% | 36.1% | 31.5% | 37.3% | 34.7% | 32.4% | 20.2% |
| Net margin ⟶audit | 9.2% | 16.3% | 15.8% | 17.0% | 16.1% | 14.8% | 18.0% | 17.7% | 21.4% | 22.9% | 20.8% | 22.6% | 20.3% | 23.9% | 22.6% | 28.9% | 9.7% |
| Revenue growth (1y) ⟶audit | — | 17.7% | 21.9% | 11.6% | 10.4% | 13.5% | 17.0% | 11.3% | 7.6% | 13.5% | 1.6% | 8.4% | 9.0% | 10.9% | 8.8% | 5.2% | 8.8% |
| Revenue growth (5y CAGR) ⟶audit | — | — | — | — | — | 15.0% | 14.8% | 12.8% | 11.9% | 12.5% | 10.1% | 8.4% | 8.0% | 8.6% | 7.7% | 8.5% | 9.3% |
| Net debt/EBITDA ⟶audit | 2.01x | 1.26x | 1.03x | 1.64x | 2.16x | 2.43x | 1.77x | 1.58x | 1.49x | 1.42x | 1.44x | 1.38x | 1.74x | 1.59x | 1.64x | 0.60x | 2.84x |
| Current ratio ⟶audit | 0.86x | 0.85x | 1.06x | 1.10x | 0.73x | 1.00x | 1.35x | 0.99x | 0.78x | 0.91x | 1.21x | 1.48x | 1.52x | 1.41x | 1.78x | 1.20x | 1.32x |
Calculation trail of each figure, down to the CVM file line: ROE calculation trail (2025) · ROIC calculation trail (2025) · ROA calculation trail (2025) · gross margin calculation trail (2025) · EBIT margin calculation trail (2025) · net margin calculation trail (2025) · revenue growth (1y) calculation trail (2025) · revenue growth (5y CAGR) calculation trail (2025) · net debt/EBITDA calculation trail (2025) · current ratio calculation trail (2025)
In reais, year by year
The three statements behind the ratios — income statement, balance sheet and cash flow — in the standardized lines, consolidated as filed (or parent-only when that is what the company files). EBITDA and net debt follow the published methodology; gross debt, cash and investments and free cash flow are sums the line names spell out.
| line | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2T26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Net revenue (R$ bn)audit | 1.5 | 1.7 | 2.1 | 2.4 | 2.6 | 3.0 | 3.5 | 3.9 | 4.2 | 4.7 | 4.8 | 5.2 | 5.7 | 6.3 | 6.8 | 7.2 | 1.9 | 7.5 | |
| Cost of goods and services (R$ bn)audit | -0.7 | -0.7 | -0.8 | -0.9 | -1.1 | -1.3 | -1.4 | -1.6 | -1.7 | -1.9 | -1.9 | -2.1 | -2.4 | -2.5 | -2.9 | -3.2 | -0.8 | -3.2 | |
| Gross profit (R$ bn)audit | 0.8 | 1.0 | 1.3 | 1.4 | 1.5 | 1.6 | 2.0 | 2.3 | 2.5 | 2.9 | 2.9 | 3.2 | 3.3 | 3.8 | 4.0 | 4.1 | 1.1 | 4.3 | |
| EBITDA (R$ bn)audit | 0.5 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 1.2 | 1.4 | 1.6 | 2.0 | 1.9 | 2.3 | 2.2 | 2.8 | 2.9 | 3.0 | — | — | |
| Depreciation and amortization (R$ m)audit | 144 | 148 | 149 | 160 | 175 | 194 | 217 | 247 | 271 | 337 | 362 | 394 | 433 | 480 | 560 | 626 | — | — | |
| EBIT (operating result) (R$ bn)audit | 0.3 | 0.5 | 0.6 | 0.6 | 0.7 | 0.7 | 1.0 | 1.1 | 1.4 | 1.6 | 1.6 | 1.9 | 1.8 | 2.3 | 2.4 | 2.3 | 0.4 | 2.0 | |
| Pre-tax profit (R$ bn)audit | 0.2 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.8 | 0.9 | 1.2 | 1.5 | 1.4 | 1.6 | 1.5 | 2.0 | 2.1 | 2.3 | -0.3 | 1.3 | |
| Income taxes (R$ m)audit | -49 | -84 | -110 | -141 | -130 | -102 | -163 | -228 | -273 | -374 | -369 | -426 | -394 | -521 | -537 | -223 | -221 | -811 | |
| Net income (R$ bn)audit | 0.1 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.6 | 0.7 | 0.9 | 1.1 | 1.0 | 1.2 | 1.2 | 1.5 | 1.5 | 2.1 | -0.5 | 0.5 | |
| Net income (controlling) (R$ bn)audit | 0.1 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.6 | 0.7 | 0.9 | 1.1 | 1.0 | 1.2 | 1.2 | 1.5 | 1.5 | 2.1 | -0.5 | 0.5 | |
| Balance sheet | |||||||||||||||||||
| Total assets (R$ bn)audit | 5.3 | 5.6 | 6.2 | 6.7 | 7.6 | 8.2 | 9.5 | 10.1 | 10.8 | 11.9 | 13.2 | 14.6 | 16.7 | 18.8 | 20.5 | 26.5 | 26.5 | 26.5 | |
| Current assets (R$ bn)audit | 0.4 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 1.3 | 1.2 | 1.1 | 1.2 | 1.8 | 2.1 | 2.5 | 2.8 | 3.3 | 7.2 | 6.3 | 6.3 | |
| Current liabilities (R$ bn)audit | 0.4 | 0.6 | 0.6 | 0.5 | 0.8 | 0.7 | 1.0 | 1.3 | 1.4 | 1.3 | 1.4 | 1.4 | 1.6 | 2.0 | 1.9 | 6.0 | 3.4 | 3.4 | |
| Gross debt (short + long term) (R$ bn)audit | 1.0 | 0.9 | 1.0 | 1.5 | 1.9 | 2.3 | 2.7 | 2.7 | 2.8 | 3.1 | 3.6 | 4.1 | 5.1 | 5.8 | 6.6 | 7.4 | 7.3 | 7.3 | |
| Cash and investments (R$ bn)audit | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.6 | 0.5 | 0.3 | 0.3 | 0.9 | 1.0 | 1.2 | 1.3 | 1.8 | 5.6 | 4.7 | 4.7 | |
| Net debt (R$ bn)audit | 0.9 | 0.8 | 0.7 | 1.3 | 1.8 | 2.2 | 2.1 | 2.2 | 2.4 | 2.8 | 2.8 | 3.1 | 3.9 | 4.5 | 4.8 | 1.8 | — | — | |
| Shareholders' equity (R$ bn)audit | 2.2 | 2.3 | 2.4 | 3.6 | 3.8 | 4.2 | 4.8 | 5.2 | 5.7 | 6.2 | 6.9 | 7.8 | 8.8 | 9.7 | 10.8 | 12.3 | 12.1 | 12.1 | |
| Cash flow | |||||||||||||||||||
| Operating cash flow (R$ bn)audit | 0.5 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 1.1 | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 2.0 | 2.4 | 2.8 | 7.1 | — | — | |
| Capital expenditures (R$ bn)audit | -0.4 | -0.4 | -0.5 | -0.8 | -1.0 | -0.8 | -0.7 | -0.8 | -1.0 | -1.0 | -1.0 | -1.3 | -1.7 | -1.9 | -1.9 | -2.6 | — | — | |
| Free cash flow (FCO + capex) (R$ bn)audit | 0.1 | 0.2 | 0.3 | 0.0 | -0.2 | 0.1 | 0.4 | 0.6 | 0.4 | 0.4 | 0.6 | 0.4 | 0.2 | 0.5 | 0.9 | 4.4 | — | — | |
The two right-hand columns come from the quarterly filing (ITR): the latest quarter alone and the last 12 months (TTM) built by the same identity as the TTM P/E. EBITDA and net debt have no quarterly series here.
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue (R$ m) | profit (R$ m) | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1! | 1,698.0 | 379.4 | 22.3% | 5.2 | 0.81 | 2024-05-09 |
| 2024T2! | 1,664.3 | 375.6 | 22.6% | 5.7 | 0.85 | 2024-08-08 |
| 2024T3! | 1,709.7 | 377.5 | 22.1% | 5.2 | 0.74 | 2024-11-07 |
| 2025T1! | 1,805.2 | 1,208.0 | 66.9% | 3.9 | 0.77 | 2025-05-08 |
| 2025T2! | 1,705.4 | 263.8 | 15.5% | 4.6 | 0.88 | 2025-08-07 |
| 2025T3! | 1,804.2 | 246.4 | 13.7% | 5.1 | 0.90 | 2025-11-06 |
| 2026T1! | 1,946.4 | 352.7 | 18.1% | 10.0 | 0.96 | 2026-05-14 |
| 2026T2! | 1,901.2 | -505.2 | -26.6% | 21.1 | 0.80 | 2026-08-13 |
Full series, every quarter: GET /empresas/SAPR11/trimestres
Dividends
No ex-date or payment scheduled in the base (exchange announcements through 2026-11-10 · filings to the regulator through 2026-11-06).
The latest dividend by SAPR11 was a JCP of R$ 0.5524 per share (record date 2025-12-30, payment 2026-06-26). In the last 12 months: 1 payments adding up to R$ 0.5524 per share (2026 so far: R$ 0.0000; 2025, full year: R$ 1.9606; by record date). Average yield of the last 5 full years: 5.9% (median 5.6%).
| type | record date | ex-date | payment | per share |
|---|---|---|---|---|
| JCP | 2025-12-30 | 2026-01-02 | 2026-06-26 | R$ 0.5524 |
| JCP | 2025-06-30 | 2025-07-01 | 2026-06-26 CVM | R$ 1.4082 |
| JCP | 2024-12-30 | 2025-01-02 | — | R$ 0.8001 |
| JCP | 2024-06-28 | 2024-07-01 | — | R$ 0.7505 |
| JCP | 2023-12-28 | 2024-01-02 | — | R$ 0.6148 |
| JCP | 2023-06-30 | 2023-07-03 | — | R$ 0.9006 |
| JCP | 2022-12-29 | 2023-01-02 | — | R$ 0.9327 |
| JCP | 2022-06-30 | 2022-07-01 | — | R$ 0.5166 |
| dividend | 2022-04-28 | 2022-04-29 | — | R$ 0.0593 |
| JCP | 2021-12-30 | 2022-01-03 | — | R$ 0.5855 |
| JCP | 2021-06-30 | 2021-07-01 | — | R$ 0.5061 |
| JCP | 2020-12-30 | 2021-01-04 | — | R$ 0.4882 |
| JCP | 2020-06-30 | 2020-07-01 | — | R$ 0.5048 |
| JCP | 2019-12-30 | 2020-01-02 | — | R$ 1.5703 |
| JCP | 2019-06-28 | 2019-07-01 | — | R$ 1.7503 |
| dividend | 2019-04-24 | 2019-04-25 | — | R$ 0.9819 |
| JCP | 2018-12-28 | 2019-01-02 | — | R$ 1.6765 |
| JCP | 2018-07-02 | 2018-07-03 | — | R$ 1.6009 |
| dividend | 2018-04-26 | 2018-04-27 | — | R$ 0.0656 |
| JCP | 2017-12-28 | 2018-01-02 | — | R$ 1.6039 |
Ex-date is the first trading session after the record date, from our own price history. Payment date comes from the exchange file; CVM marks a date taken from the filing to the regulator. Only the main ticker class.
Record dates in the last 5 years, by month: JanFebMarApr1MayJun4JulAugSepOctNovDec5
Per year
| year | per share | payments | dividends | gross JCP | other | net JCP (est.) | yield | return of capital (not in total) |
|---|---|---|---|---|---|---|---|---|
| 2025 | R$ 1.9606 | 2 | 0.0000 | 1.9606 | 0.0000 | 1.6665 | 4.9% | — |
| 2024 | R$ 1.5506 | 2 | 0.0000 | 1.5506 | 0.0000 | 1.3180 | 5.6% | — |
| 2023 | R$ 1.5154 | 2 | 0.0000 | 1.5154 | 0.0000 | 1.2881 | 5.2% | — |
| 2022 | R$ 1.5086 | 3 | 0.0593 | 1.4493 | 0.0000 | 1.2319 | 8.4% | — |
| 2021 | R$ 1.0916 | 2 | 0.0000 | 1.0916 | 0.0000 | 0.9279 | 5.7% | — |
| 2020 | R$ 0.9930 | 2 | 0.0000 | 0.9930 | 0.0000 | 0.8441 | 3.8% | — |
| 2019 | R$ 4.3025 | 3 | 0.9819 | 3.3206 | 0.0000 | 2.8225 | 4.2% | — |
| 2018 | R$ 3.3430 | 3 | 0.0656 | 3.2774 | 0.0000 | 2.7858 | 5.4% | — |
| 2017 | R$ 1.6039 | 1 | 0.0000 | 1.6039 | 0.0000 | 1.3633 | 2.7% | — |
Yield per year = the year's dividends over the close of its last session; the current year is partial. Dividends are tax-exempt for individuals; net JCP is an ESTIMATE after the 15% withholding.
Shareholders and free float
1,208,531,711 sharesshares outstanding held by the market, as filed in the FRE
519,019 individuals · 1,035 companies · 798 institutionalcount at the last shareholders meeting, from the FRE
as declared in the FREshareholders the company marks as controlling
Nível 2 de Governança Corporativaminimum guaranteed by the listing segment or by law; the bylaws may grant more
| shareholder | type | % ON | % PN | % total |
|---|---|---|---|---|
| Estado do Paraná ctrl | PJ | 60.08% | 0.00% | 20.03% |
| Blackrock, Inc | PJ | 2.49% | 5.54% | 4.53% |
| Others (market) | — | — | — | 75.45% |
| Treasury shares | — | — | — | 0.00% |
Direct holdings from the reference form (FRE) filed on 2026-09-22, version 6. The chain of control (who owns the holding) is not reproduced here. Names of individuals appear as in the public filing.
Funds that hold this stock
Of 326 funds holding it on 2026-04-30: 112 increased, 66 reduced, 56 are new and 77 sold out compared with 2026-03.
| fund | shares | market value | change vs previous month | |
|---|---|---|---|---|
| DIMORAES FUNDO DE INVESTIMENTO FINANCEIRO EM AÇÕES 09.094.156/0001-53 | 3,000,000 | R$ 121.6 mn | 0 (0.0%) | unchanged |
| FUNDO DE INVESTIMENTO EM ACOES GUAXE MASTER 36.247.991/0001-59 | 1,160,000 | R$ 47.0 mn | 0 (0.0%) | unchanged |
| CAIXA MASTER AÇÕES LIVRE QUANTITATIVO FUNDO DE INVESTIMENTO FINANCEIRO EM AÇÕES - RESP LIMITADA 30.036.209/0001-76 | 999,750 | R$ 40.5 mn | +76,600 (+8.3%) | increased |
| ECLIPSEON FUNDO DE INVESTIMENTO EM AÇÕES 22.918.444/0001-43 | 773,120 | R$ 31.3 mn | 0 (0.0%) | unchanged |
| AZ QUEST SMALL MID CAPS MASTER FUNDO DE INVESTIMENTO FINANCEIRO EM AÇÕES RESPONSABILIDADE LIMITADA 11.403.884/0001-41 | 760,189 | R$ 30.8 mn | -3,694 (-0.5%) | unchanged |
| FUNDO DE INVESTIMENTO FINANCEIRO MULTIMERCADO LS 11.233.045/0001-22 | 734,237 | R$ 29.8 mn | -297,100 (-28.8%) | reduced |
| MAMORÉ FUNDO DE INVESTIMENTO FINANCEIRO EM AÇÕES RESPONSABILIDADE LIMITADA 10.254.029/0001-53 | 532,244 | R$ 21.6 mn | 0 (0.0%) | unchanged |
| VIROFLAY FIF PREVIDENCIÁRIO CLASSE DE INVESTIMENTO MULTIMERCADO PREV RESP LIMITADA 30.056.841/0001-81 | 509,600 | R$ 20.7 mn | 0 (0.0%) | unchanged |
| PS EQUITY INFLATION FUNDO DE INVESTIMENTO FINANCEIRO EM AÇÕES 50.425.078/0001-26 | 441,183 | R$ 17.9 mn | -2,900 (-0.7%) | reduced |
| PERFIN INFRA EQUITY MASTER FUNDO DE INVESTIMENTO EM AÇÕES 39.344.972/0001-39 | 430,000 | R$ 17.4 mn | +149,500 (+53.3%) | increased |
The 10 largest by value, out of 326; together the funds hold 19,116,114 shares (R$ 775.0 mn). Full list: GET /empresas/SAPR11/fundos.
Reference date: 2026-04-30. The CVM already has a file for 2026-10, but with only about 7% of the funds of a full month, so it is not used. The portfolio is the position on the last day of the reference month. The CVM publishes it only AFTER the month ends, and recent months arrive incomplete for months; it also keeps apart the positions a fund asked to hold confidential for a period (not included here): the snapshot is always older than today, and a fund may have changed since. Change = difference in the number of shares against the previous month (not in value, which also moves with the price). Lent shares are not counted. Description of public data, no recommendation. Source: CVM open data, CDA (block 4, shares), dados.cvm.gov.br, license ODbL 1.0.
Latest material fact
SAPR11 filed with the CVM a Material Fact on 2026-10-28: Resultado da Licitação para de Locação de Ativos - SAINP.
original document at the CVM · all recent material facts
Descriptive index of what the company filed with the CVM; we do not summarise or interpret it. The CVM open data is updated weekly, so the document may have been filed days before it shows here.
Insider trading (by role)
No on-market purchase or sale by insiders was reported in the last 12 months.
| Month | Executive officers | Board of directors | Controlling shareholder | Others (audit board, technical bodies) |
|---|---|---|---|---|
| 2026-10 | — | — | — | — |
| 2026-09 | — | — | — | — |
| 2026-08 | — | — | — | — |
| 2026-07 | — | — | — | — |
| 2026-06 | — | — | — | — |
| 2026-05 | — | — | — | — |
| 2026-04 | — | — | — | — |
| 2026-03 | — | — | — | — |
| 2026-02 | — | — | — | — |
| 2026-01 | — | — | — | — |
| 2025-12 | — | — | — | — |
| 2025-11 | — | — | — | — |
Source: CVM open data, Securities Traded and Held (art. 11 of CVM Resolution 44), licence ODbL, updated weekly by the CVM. Sums by type of person; no individual is named. Only on-market purchases and sales of the company's own shares and units; balances, subscriptions, pay plans, loans and forward trades are left out. Reais count only trades with a reported value (the others are counted, not valued). Not investment advice. largest net buys and sells · JSON
Filings and notices
| filed | category | subject | document |
|---|---|---|---|
| 2026-11-06 | Valores Mobiliários negociados e detidos (art. 11 da Instr. CVM nº 358) · Posição Consolidada | — | open |
| 2026-11-03 | Reunião da Administração · Conselho de Administração | 1. Assuntos gerais: Precatórios - informações referentes as tratativas dos precatórios junto a Agepar.||10. Deliberar sobre a proposta de revisão do Regimento Interno da Auditoria, | open |
| 2026-11-03 | Reunião da Administração · Conselho de Administração | 1. Assuntos gerais: Precatórios - informações referentes as tratativas dos precatórios junto a Agepar.||10. Deliberar sobre a proposta de revisão do Regimento Interno da Auditoria, | open |
| 2026-10-28 | Comunicado ao Mercado · Esclarecimentos sobre questionamentos da CVM/B3 | Resposta ao Ofício nº 246/2026/CVM/SEP/GEA-2 | open |
| 2026-10-28 | Fato Relevante | Resultado da Licitação para de Locação de Ativos - SAINP | open |
| 2026-10-26 | Fato Relevante | Fato Relevante - Homologação do Acordo do 1º TA ao Termo de Compromisso Ambiental relativo à repactuação de Termos de Acordos Judiciais (TAJ) | open |
| 2026-10-20 | Reunião da Administração · Conselho Fiscal | 1. Apresentar os resultados econômicos e financeiros do período de janeiro a agosto de 2026.||2. Analisar a proposta de integralização ao capital social do saldo das Reservas de Lu | open |
| 2026-10-13 | Comunicado ao Mercado · Outros Comunicados Não Considerados Fatos Relevantes | Abertura, pela Agepar, da Consulta Pública nº 006-2026 sobre Atualização da metodologia de reajuste tarifário | open |
| 2026-10-06 | Valores Mobiliários negociados e detidos (art. 11 da Instr. CVM nº 358) · Posição Consolidada | — | open |
| 2026-10-01 | Estatuto Social | — | open |
The last filings this company sent to the CVM outside its financial statements, newest first, from the regulator's own IPE index. The subject line is the company's own free text. We do not summarise or classify these documents — read the original.
Piotroski F-Score 6/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2010 | BPA 1 (individual) | 5,306.9 | 5,183.0 |
| 2010 | BPP 2 (individual) | 5,306.9 | 5,183.0 |
| 2021 | DRE 3.02 (individual) | -2,050.7 | -2,120.0 |
| 2021 | DRE 3.03 (individual) | 3,153.7 | 3,084.4 |
| 2010 | DRE 3.05 (individual) | 312.3 | 332.6 |
| 2010 | DRE 3.07 (individual) | 184.0 | 204.4 |
| 2010 | DMPL 5.05.01 (individual) | 135.5 | 148.9 |
| 2010 | DRE 3.09 (individual) | 135.5 | 148.9 |
Every restatement of this company, year by year
This company appears in
Compare
Side by side, with each figure's caveat and how often each company restated its filings.
SAPR11 × AXIA3 · SAPR11 × CPLE3 · SAPR11 × SBSP3 · SAPR11 × EQTL3 · SAPR11 × CPFE3 · SAPR11 × EGIE3
compare with the sector: SBSP3 × CSMG3 × SAPR11
Dividends and returns in the sector
The largest in the same sector by market value: what they paid and what R$ 1,000 became.
- AXIA3: dividends · how much it returned
- CPLE3: dividends · how much it returned
- SBSP3: dividends · how much it returned
- EQTL3: dividends · how much it returned
- CPFE3: dividends · how much it returned
- EGIE3: dividends · how much it returned
On the dated lists: Stocks with a P/E below 10 (#20)
Other companies in Utilities
46 more with a page, same CVM sector — a classification of the regulator's, not ours.
Questions about SAPR11: P/E, dividend yield, ROE and filings
What was the ROIC of CIA. DE SANEAMENTO DO PARANÁ - SANEPAR (SAPR11) over the last 5 years?
ROIC of CIA. DE SANEAMENTO DO PARANÁ - SANEPAR (SAPR11), clean values (no flag) of the last years with the figure: 2021: 13.3%; 2022: 11.3%; 2023: 13.0%; 2024: 11.8%; 2025: 14.2%. Each figure links to the CVM account it came from at https://dadosb3.com/acoes/SAPR11.
Has CIA. DE SANEAMENTO DO PARANÁ - SANEPAR (SAPR11) ever restated its financial statements? In which years?
Yes. The statements for 2010, 2021 came back with different figures in the following year's annual filing. Year, account and both values: https://dadosb3.com/acoes/SAPR11/reapresentacoes
What is the net debt to EBITDA of CIA. DE SANEAMENTO DO PARANÁ - SANEPAR (SAPR11) in the last filing, and how does it compare with the sector?
Net debt to EBITDA of 0.6 in 2025; sector median 2.8 (43 companies); the company itself ranged from 0.6 to 2.4 between 2010 and 2025; 71% of the 300 companies in the base are above; debt up to 2 times EBITDA.
Did CIA. DE SANEAMENTO DO PARANÁ - SANEPAR (SAPR11) have ROIC above 15% and net debt to EBITDA below 2 in the last filing?
In 2025: ROIC 14.2% (not above 15%) and net debt to EBITDA 0.60x (below 2).
What is the P/E of CIA. DE SANEAMENTO DO PARANÁ - SANEPAR (SAPR11) in the last filing, and the date of the price used?
P/E 6.7 for 2025, price of 26/02/2026 — the first session after that year's filing reached the CVM (point-in-time, not the 31 December price).
What is the P/E of SAPR11 today?
12-month P/E of 21.6: market value at the close of 2026-11-12 ÷ net income of the last 12 months to 2T26 (four quarterly filings).
What is the ROE of SAPR11?
ROE of 2025: 17.9%, from the 2025 annual statements (DFP) filed with the CVM. Over the 12 months to 2T26: 3.8%.
Take this into your code
GET /empresas/SAPR11/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 2,230 sessions, 2017-11-22 → 2026-11-12 · methodology · how we verify
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-11-09-ancora-do-fre · page generated 2026-11-13 11:32 UTC. If this does not match /saude, you are reading a cached copy.